MarketCap
Facebook
X
TelegramGeschäftsbericht 2022
hinzugefügt 25.07.2022
Taro Pharmaceutical Industries Ltd. P/S 2011-2026 | TARO
P/S Jährlich Taro Pharmaceutical Industries Ltd.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.41 | 3.34 | 4.24 | 6.25 | 5.4 | 4.79 | 5.5 | 6.1 | 5.72 | 3.52 | 11.8 | 2.43 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 11.8 | 2.41 | 5.13 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M |  Germany |
 |
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K |  USA |
 |
BioNTech SE
BNTX
|
35.7 | $ 95.5 | - | $ 27.2 B | Germany |
 |
I-Mab
IMAB
|
94.1 | - | - | $ 866 M |  China |
 |
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B |  France |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | USA |
 |
Edesa Biotech
EDSA
|
158 | $ 15.46 | - | $ 49.4 M | USA |
 |
Esperion Therapeutics
ESPR
|
1.39 | $ 3.11 | - | $ 646 M | USA |
 |
Exelixis
EXEL
|
5.05 | $ 44.42 | - | $ 12.1 B | USA |
 |
Fortress Biotech
FBIO
|
1.23 | $ 2.46 | - | $ 68.6 M | USA |
 |
Fennec Pharmaceuticals
FENC
|
3.78 | $ 6.72 | - | $ 192 M | USA |
 |
Hutchison China MediTech Limited
HCM
|
60.7 | $ 13.3 | - | $ 11.4 B | China |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - |  Russia |
 |
Immuron Limited
IMRN
|
207 | $ 0.79 | - | $ 8.53 M |  Australia |
 |
INmune Bio
INMB
|
564 | $ 1.54 | - | $ 38.1 M | USA |
 |
Ionis Pharmaceuticals
IONS
|
63.5 | $ 75.25 | - | $ 12 B | USA |
 |
KalVista Pharmaceuticals
KALV
|
17 | $ 26.71 | - | $ 1.44 B | Britain |
 |
ACADIA Pharmaceuticals
ACAD
|
3.33 | $ 22.35 | - | $ 3.7 B | USA |
 |
Kamada Ltd.
KMDA
|
2.61 | $ 8.21 | - | $ 260 M |  Israel |
 |
Kymera Therapeutics
KYMR
|
202 | $ 82.71 | - | $ 6.99 B | USA |
 |
Galapagos NV
GLPG
|
18.9 | $ 28.39 | - | $ 2.69 B |  Belgium |
 |
Grifols, S.A.
GRFS
|
1.71 | $ 8.27 | - | $ 6.83 B |  Spain |
 |
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 3.5 | - | $ 5.76 M | Israel |
 |
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M |  Canada |
 |
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | USA |
 |
Mirum Pharmaceuticals
MIRM
|
10.4 | $ 105.81 | - | $ 5.31 B | USA |
 |
MannKind Corporation
MNKD
|
2.84 | $ 2.86 | - | $ 874 M | USA |
 |
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | USA |
 |
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 23.42 | - | $ 2.98 B | USA |
 |
Nanobiotix S.A.
NBTX
|
98.9 K | $ 34.77 | - | $ 286 B | France |
 |
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | USA |